Role of clinical, patient-reported outcome and medico-economic studies in the public hospital drug formulary decision-making process: results of a European survey
- 28 February 2005
- journal article
- Published by Elsevier in Health Policy
- Vol. 71 (2) , 205-212
- https://doi.org/10.1016/j.healthpol.2004.08.007
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Criteria to Request Pharmacoeconomic Data and Data Sources for Hospital Formulary DecisionsDrug Information Journal, 2001
- Differences in Attitudes, Knowledge and Use of Economic Evaluations in Decision-Making in The NetherlandsPharmacoEconomics, 2000
- Research into the use of health economics in decision making in the United Kingdom—Phase IIHealth Policy, 1999
- Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitalsInternational Journal of Clinical Pharmacy, 1999
- Structure and activities of hospital drug committees in GermanyEuropean Journal of Clinical Pharmacology, 1997
- Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysisSocial Science & Medicine, 1997
- Models of Hospital Drug Policy in the UKJournal of Health Services Research & Policy, 1997
- Will Managed Care Work in Europe?PharmacoEconomics, 1997
- The Expanding Role of Pharmacy and Therapeutics CommitteesPharmacoEconomics, 1996
- Pharmacoeconomics and Formulary Decision MakingPharmacoEconomics, 1996